TerminatedNCT03671005
Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders
Behavioural studyAges 18–65Germany
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- BerlinSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 1, 2018
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 40
- Sponsor
- Charite University, Berlin, Germany
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Other
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT03671005
- Official title
Show the full official title
Mindfulness-based Group Therapy for Inpatients With Schizophrenia Spectrum Disorders
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Berlin
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Charite University, Berlin, Germany, a university.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to explore more studies?
Explore studiesRelated studies
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
26-week open-label extension study evaluating the safety and tolerability of flexible doses of oral ziprasidone in adolescent subjects with schizophrenia.